New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin‐3‐Carboxylic Acid as Antiproliferative Agents
Open Access
- 1 January 2007
- journal article
- research article
- Published by Wiley in Metal-Based Drugs
- Vol. 2007 (1) , 15925
Abstract
New complexes of samarium(III), gadolinium(III), and dysprosium(III) with coumarin‐3‐carboxylic acid (HCCA) were prepared by the reaction of the ligand with respective metal nitrates in ethanol. The structures of the final complexes were determined by means of physicochemical data, elemental analysis, IR and Raman spectra. The metal‐ligand binding mode in the new Ln(III) complexes of coumarin‐3‐carboxylic acid was elucidated. The vibrational study gave evidence for bidentate coordination of CCA− to Ln(III) ions through the carbonylic oxygen and the carboxylic oxygen atoms. The complexes were tested for antiproliferative activitiy on the chronic myeloid leukemia‐derived K‐562, overexpressing the BCR‐ABL fusion protein. Cytotoxicity towards tumor cells was determined for a broad concentration range. The samarium salt exerted a very weak antiproliferative effect on these cells. This is in contrast to the lanthanide complexes, especially samarium complex, which exhibited potent antiproliferative activity. The present study confirms our previous observations that the lanthanide complexes of coumarins exhibit antiproliferative activity towards K‐562 cell line.Keywords
This publication has 29 references indexed in Scilit:
- Theoretical and spectroscopic evidence for coordination ability of 3,3′-benzylidenedi-4-hydroxycoumarin. New neodymium (III) complex and its cytotoxic effectJournal of Inorganic Biochemistry, 2005
- Cytotoxic activity of new neodymium (III) complexes of bis-coumarinsEuropean Journal of Medicinal Chemistry, 2004
- Synthesis, physicochemical characterization and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Niffcoumar sodium saltEuropean Journal of Medicinal Chemistry, 1999
- Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potentialGeneral Pharmacology: The Vascular System, 1996
- An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarinJournal of Cancer Research and Clinical Oncology, 1994
- Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinomaJournal of Cancer Research and Clinical Oncology, 1994
- Treatment with coumarin to prevent or delay recurrence of malignant melanomaJournal of Cancer Research and Clinical Oncology, 1994
- Antitumour activity of coumarin in prostate and mammary cancer modelsJournal of Cancer Research and Clinical Oncology, 1994
- The effects of coumarin and suramin on the growth of malignant renal and prostatic cell linesJournal of Cancer Research and Clinical Oncology, 1994
- Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitroJournal of Cancer Research and Clinical Oncology, 1994